Methamphetamine: Effects on the brain, gut and immune system
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
&NA; Methamphetamine (METH) is a powerful central nervous system stimulant which elevates mood, alertness, energy levels and concentration in the short‐term. However, chronic use and/or at higher doses METH use often results in psychosis, depression, delusions and violent behavior. METH was formerly used to treat conditions such as obesity and attention deficit hyperactivity disorder, but now is primarily used recreationally. Its addictive nature has led to METH abuse becoming a global problem. At a cellular level, METH exerts a myriad of effects on the central and peripheral nervous systems, immune system and the gastrointestinal system. Here we present how these effects might be linked and their potential contribution to the pathogenesis of neuropsychiatric disorders. In the long term, this pathway could be targeted therapeutically to protect people from the ill effects of METH use. This model of METH use may also provide insight into how gut, nervous and immune systems might break down in other conditions that may also benefit from therapeutic intervention. Graphical abstract Figure. No caption available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structural and functional features of central nervous system lymphatic vessels
Louveau, A., Smirnov, I., Keyes, T. J., Eccles, J. D., Rouhani, S. J., Peske, J. D., Derecki, N. C., Castle, D., Mandell, J. W., Lee, K. S., et al. (2015) · Nature · doi:10.1038/nature14432 · Cited by 4,413
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin
Borovikova, L. V., Ivanova, S., Zhang, M., Yang, H., Botchkina, G. I., Watkins, L. R., Wang, H., Abumrad, N., Eaton, J. W., & Tracey, K. J. (2000) · Nature · doi:10.1038/35013070 · Cited by 4,211
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · cited 1×
“Therefore the intestinal microbiota may act as a mediator in the communication between the gut and the brain (75).”
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503 · cited 2×
“Current evidence suggests that multiple mechanisms, including immune, endocrine and neuroendocrine pathways, may be involved in gut microbiota-to-brain signalling and that the brain can in turn alter microbial composition and behaviour via the enteric nervous system (79-81).”
HMGB1: Endogenous Danger Signaling
Klune, J. R., Dhupar, R., Cardinal, J., Billiar, T. R., & Tsung, A. (2008) · Molecular Medicine · doi:10.2119/2008-00034.klune · Cited by 762
Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592
KERMODE, A. G., THOMPSON, A. J., TOFTS, P., MACMANUS, D. G., KENDALL, B. E., KINGSLEY, D. P. E., MOSELEY, I. F., RUDGE, P., & MCDONALD, W. I. (1990) · Brain · doi:10.1093/brain/113.5.1477 · Cited by 578
Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines
Johnson, J. D., Campisi, J., Sharkey, C. M., Kennedy, S. L., Nickerson, M., Greenwood, B. N., & Fleshner, M. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.090 · Cited by 424
Cadet, J. L., Jayanthi, S., & Deng, X. (2003) · The FASEB Journal · doi:10.1096/fj.03-0073rev · Cited by 286 · cited 1×
“The phosphorylation of PI3/Akt molecules via glutamate receptor engagement leads to the activation of transcription factor NF-κ B and ultimately facilitates inflammation, neurotoxicity and apoptosis (108).”
Stress at the intestinal surface: catecholamines and mucosa–bacteria interactions
Lyte, M., Vulchanova, L., & Brown, D. R. (2011) · Cell and Tissue Research · doi:10.1007/s00441-010-1050-0 · Cited by 281 · cited 1×
“Extensive release of dopamine and norepinephrine stimulates growth of bacteria which may also influence neural activity in stress responsive brain areas (74).”
The vagal innervation of the gut and immune homeostasis
Matteoli, G., & Boeckxstaens, G. E. (2013) · Gut · doi:10.1136/gutjnl-2012-302550 · Cited by 276 · cited 1×
“The vagus nerve also indirectly modulates immune activity of the spleen through connections with the splenic sympathetic nerve (67, 68).”
Miller, G. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07109.x · Cited by 249 · cited 1×
“It is an intracellular receptor predominantly found in the cytoplasm of presynaptic terminals and is poorly expressed on the cell membrane (45).”
Effect of dopamine on gastrointestinal motility during critical illness
Dive, A., Foret, F., Jamart, J., Bulpa, P., & Installé, E. (2000) · Intensive Care Medicine · doi:10.1007/s001340051279 · Cited by 124 · cited 1×
“In the gut, dopamine and norepinephrine act on receptors of the enteric nervous system resulting in decreased bowel contractility, intestinal smooth muscle tone and alteration of the migratory motor complex (76-78).”
Impact of methamphetamine on infection and immunity
Salamanca, S. A., Sorrentino, E. E., Nosanchuk, J. D., & Martinez, L. R. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00445 · Cited by 116 · cited 1×
“METH use is associated with severe neurological and physical consequences (e.g. paranoia, violent behaviour, psychosis, anxiety and depression) and has become a serious public health problem worldwide (2, 3).”
Harms, R., Morsey, B., Boyer, C. W., Fox, H. S., & Sarvetnick, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049897 · Cited by 81 · cited 4×
“METH modifies a number of immune cell (natural killer (NK) cells, dendritic cells (DC), monocytes, macrophages and granulocytes) activities, leading to immunosuppression (86).”
InfluentialStress-induced remodeling of lymphoid innervation
Sloan, E. K., Capitanio, J. P., & Cole, S. W. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.06.011 · Cited by 62 · cited 1×
“The sympathetic nervous system is involved in stress-induced remodelling of lymph node innervation; increased norepinephrine and epinephrine levels inhibit immune cell functions and promote intestinal inflammation (60-62).”
Cited by
Jones, C. M., Houry, D., Han, B., Baldwin, G., Vivolo‐Kantor, A., & Compton, W. M. (2022) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14688 · Cited by 202
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008–17
Jones, C. M., Underwood, N., & Compton, W. M. (2020) · Addiction · doi:10.1111/add.14812 · Cited by 142
Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76
Factors associated with methamphetamine withdrawal symptoms among people who inject drugs
Zhao, J., Kral, A. H., Simpson, K. A., Ceasar, R. C., Wenger, L. D., Kirkpatrick, M., & Bluthenthal, R. N. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108702 · Cited by 29
Rapid assessment of nutrition services in Los Angeles substance use disorder treatment centers
Wiss, D. A., Schellenberger, M., & Prelip, M. L. (2019) · Journal of Community Health · doi:10.1007/s10900-018-0557-2 · Cited by 25
Metadata
- Authors
- Prakash, M. D., Tangalakis, K., Antonipillai, J., Stojanovska, L., Nurgali, K., & Apostolopoulos, V.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 120
- Pages
- 60-67
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2595992673
- Cited by
- 219
- References
- 16
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.